Abstract:
The present invention relates to a composition for alleviating allergic skin diseases. The present invention relates to a composition for alleviating atopic dermatitis which includes a hijikia fusiforme extract for inducing the normalization of cytokine generation and lesion tissues of cytokine which causes atopic dermatitis or including an active fraction separated therefrom through chromatography as an active ingredient from among natural materials which rarely have side effects.
Abstract:
PURPOSE: A composition containing Ilex rotunda leaf extract or caffeoyl derivatives is provided to enhance antioxidative function and to remove free radical. CONSTITUTION: A composition for treating, preventing, or relieving atopic dermatitis contains 3,4-di-caffeoylquinic acid, 3,5-di-caffeoylquinic acid, or 3,4,5-tri-caffeoylquinic acid as an active ingredient. The composition is a pharmaceutical composition for treating or preventing atopic dermatitis. The pharmaceutical composition is manufactured in the form of an external use skin formulation. A composition for treating, preventing, or relieving atopic dermatitis contains Ilex rotunda leaf extract as an active ingredient.